Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 40,280,221 |
|
|||||
| News | - | ||||||
| Day High | 7.74 | Low High |
|||||
| Day Low | 4.9201 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ImmunityBio Inc | IBRX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 2.49 | 48.73% | 7.60 | 18:59:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.11 | 4.9201 | 7.74 | 7.35 | 5.11 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 183,628 | 40,280,221 | US$ 6.21 | US$ 250,337,735 | - | 1.25 - 7.74 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:58 | formt | 335 | US$ 7.60 | USD |
ImmunityBio (IBRX) Options Flow Summary
ImmunityBio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 21.69B | 667.71M | - | 622k | -583.2M | -0.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ImmunityBio News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IBRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.91 | 7.74 | 4.79 | 5.28 | 11,230,121 | 2.69 | 54.79% |
| 1 Month | 5.35 | 7.74 | 4.73 | 5.39 | 5,856,676 | 2.25 | 42.06% |
| 3 Months | 3.53 | 7.74 | 3.37 | 5.05 | 4,910,123 | 4.07 | 115.30% |
| 6 Months | 1.69 | 7.74 | 1.62 | 4.21 | 5,330,080 | 5.91 | 349.70% |
| 1 Year | 2.37 | 7.74 | 1.25 | 3.60 | 4,526,567 | 5.23 | 220.68% |
| 3 Years | 18.74 | 19.72 | 1.21 | 4.46 | 2,723,822 | -11.14 | -59.45% |
| 5 Years | 36.55 | 40.834 | 1.21 | 4.87 | 2,663,645 | -28.95 | -79.21% |
ImmunityBio Description
| ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory. |
